P4HTM
protein-codingprolyl 4-hydroxylase, transmembrane
Gene summary
The product of this gene belongs to the family of prolyl 4-hydroxylases. This protein is a prolyl hydroxylase that may be involved in the degradation of hypoxia-inducible transcription factors under normoxia. It plays a role in adaptation to hypoxia and may be related to cellular oxygen sensing. Alternatively spliced variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~17.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032780
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0032780
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0032780
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0032780
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic; Ophthalmologic; Pulmonary
Intervention: Pulmonary
Rationale: Individuals have been described with respiratory difficulties, including bradypnea, hypoventilation, recurrent pneunomia, and sleep apnea (often requiring nighttime BiPAP), and awareness may allow early management of pulmonary issues
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to P4HTM variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_177939.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 21 | 22 | |||
| missense | 1 | 5 | 83 | 5 | 94 | |
| nonsense | 3 | 1 | 4 | |||
| start loss | 0 | |||||
| frameshift | 1 | 2 | 2 | 5 | ||
| splice donor/acceptor (+/-2bp) | 2 | 3 | 5 | |||
| Total | 5 | 9 | 90 | 26 | 0 | 130 |
Highest pathogenic variant AF is 0.00003717435
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_808808.1 | 9 | MANE Select | |
| Ensembl | ENSP00000373235.4 | 9 | MANE Select | |
| RefSeq | NP_808807.2 | 9 | Standard | |
| Ensembl | ENSP00000341422.4 | 9 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| p4htm | Danio rerio | Structure: lens capsule Quality: broken abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- peptidyl-proline hydroxylation to 4-hydroxy-L-proline
- regulation of erythrocyte differentiation
- oxidation-reduction process
Molecular Function
- procollagen-proline 4-dioxygenase activity
- iron ion binding
- calcium ion binding
- 2-oxoglutarate-dependent dioxygenase activity
- L-ascorbic acid binding
Cellular Component
- endoplasmic reticulum
- endoplasmic reticulum membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000343546
- Coding exons
- 9
- Length
- 17269
- Individuals with no LoFs
- 125714
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 34
- Defined
- 125748
- p
- 0.000135
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.54 | 253 | 332 | 0.762 | 0.0000188 | 3632 |
| Missense (PolyPhen) | 88 | 135.43 | 0.64979 | 1482 | ||
| Synonymous | 0.233 | 134 | 137 | 0.975 | 0.00000763 | 1165 |
| Loss of Function | 1.54 | 17 | 25.4 | 0.670 | 0.00000117 | 263 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00017 | 0.00016 | rare |
| Finnish | 0.000093 | 0.000092 | rare |
| European (Non-Finnish) | 0.00010 | 0.000097 | rare |
| South Asian | 0.00026 | 0.00026 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalyzes the post-translational formation of 4- hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. Hydroxylates HIF1A at 'Pro-402' and 'Pro-564'. May function as a cellular oxygen sensor and, under normoxic conditions, may target HIF through the hydroxylation for proteasomal degradation via the von Hippel-Lindau ubiquitination complex. {ECO:0000269|PubMed:17726031}.;
Recessive Scores
- pRec
- 0.153
Intolerance Scores
- LoFtool
- 0.215
- RVIS EVS
- -0.09
- RVIS percentile EVS
- 46.92
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.644
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |